NEPH vs RJF · P/E 48, rev $11.2M vs rev $15.91B
Nephros Inc (NEPH) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
RJF (RJF) common stock.
Latest reported NEPH revenue for 2026-06-30 was $11.2M. Net income was $1.3M. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
NEPH currently screens at market cap $40.9M and trailing P/E 48.3. RJF currently screens at market cap $0.
Not investment advice. Open the NEPH and RJF stock pages for the full models.
Not investment advice.